Valuation: Acarix AB

Market Cap 260M 25.9M 23.01M 21.48M 19.57M 36.92M 2.49B 37.26M 101M 1.27B 97.23M 95.12M 4.08B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 260M 25.9M 23.01M 21.48M 19.57M 36.92M 2.49B 37.26M 101M 1.27B 97.23M 95.12M 4.08B EV / Sales 2026 *
18.6x
EV / Sales 2027 * 8.12x
Free-Float
89.13%
Yield 2026 *
-
Yield 2027 * -
1 day-0.95%
1 week+6.89%
Current month+8.10%
1 month-11.04%
3 months-18.64%
6 months-23.40%
Current year-21.83%
1 week 0.18
Extreme 0.18
0.22
1 month 0.18
Extreme 0.18
0.25
Current year 0.18
Extreme 0.18
0.33
1 year 0.18
Extreme 0.18
0.35
3 years 0.17
Extreme 0.1688
0.6
5 years 0.17
Extreme 0.1688
1.47
10 years 0.17
Extreme 0.1688
26.8
Manager TitleAgeSince
Chief Executive Officer - 01/02/2024
Chief Executive Officer 62 23/02/2018
Director TitleAgeSince
Director/Board Member 61 01/01/2020
Director/Board Member 52 14/05/2024
Director/Board Member - 14/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-0.95%+6.89%-29.82%-16.03% 26.11M
+0.35%-2.99%+24.73%+32.07% 241B
+1.09%-4.65%+1.77%+0.15% 149B
-2.32%-3.27%-11.53%+32.87% 142B
-1.46%-3.01%-55.73%-19.33% 62.65B
-0.05%-1.32%+11.09%+23.08% 49.1B
+0.66%+1.75%-18.23%-21.12% 47.13B
+0.66%-2.90%+20.97%+51.29% 46.99B
-3.05%-2.62%-9.13%+35.86% 45.65B
-0.08%-1.92%+32.09%+57.18% 41.81B
Average -0.25%-1.09%-3.38%+17.60% 82.52B
Weighted average by Cap. +0.14%-2.63%+3.27%+21.55%

Financials

2026 *2027 *
Net sales 14M 1.4M 1.24M 1.16M 1.05M 1.99M 134M 2.01M 5.43M 68.56M 5.24M 5.12M 220M 32M 3.19M 2.83M 2.64M 2.41M 4.55M 307M 4.59M 12.4M 157M 11.97M 11.71M 503M
Net income -30.8M -3.07M -2.73M -2.55M -2.32M -4.38M -295M -4.42M -11.94M -151M -11.52M -11.27M -484M -15.3M -1.52M -1.35M -1.26M -1.15M -2.17M -147M -2.19M -5.93M -74.92M -5.72M -5.6M -240M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change Volume
02/10/26 SEK 0.2095 -0.95% 1,384,138
01/10/26 SEK 0.2115 +9.13% 3,116,473
30/09/26 SEK 0.1938 -3.58% 1,541,623
29/09/26 SEK 0.2010 +7.72% 3,266,174
28/09/26 SEK 0.1866 -7.16% 3,513,909

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACARIX Stock